We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Horizon Discovery and Desktop Genetics Collaborate on CRISPR Design Platform
News

Horizon Discovery and Desktop Genetics Collaborate on CRISPR Design Platform

Horizon Discovery and Desktop Genetics Collaborate on CRISPR Design Platform
News

Horizon Discovery and Desktop Genetics Collaborate on CRISPR Design Platform

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Horizon Discovery and Desktop Genetics Collaborate on CRISPR Design Platform"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Horizon Discovery announced it has entered into a collaboration agreement with Desktop Genetics for development of a CRISPR design platform.  The platform will be used by Horizon to quickly identify the best guide-RNAs in the human genome for each gene editing task, as part of its GENESIS™ suite of gene editing technologies.

Desktop Genetics will design and implement algorithms for the new platform based on Horizon's input and CRISPR knowledge. Horizon licensed the CRISPR gene editing technology from Harvard University in September 2013, adding to its existing rAAV and ZFN gene editing capabilities. Through its GENESIS™ precision gene-editing platform, Horizon offers researchers an unrivalled toolbox capable of performing rapid functional genomics experiments, as well as creation of high-precision human disease models for deployment at all stages of drug discovery and diagnostic development. 

“Horizon is placing significant  investment in ensuring our scientists and customers have access to the best gene editing technology, or combination of technologies, to most effectively achieve their goals,” commented Eric Rhodes, CTO, Horizon Discovery. “We are committed to ensuring that we continue to be able to offer our customers a best-in-class solution for their research needs.”

Riley Doyle, CEO of Desktop Genetics, said: “Desktop Genetics develops novel software tools that are optimized for applications in gene expression, antibody engineering, cell line development, functional genomics, gene-editing and protein production. We are excited to be working with Horizon, a leader in its field, on its application of the cutting-edge CRISPR technology, and on expanding our offerings in the growing fields of genome and cell line engineering.” 

Advertisement